As researchers glean new insights into the dynamic inner world of the human immune system, it has become increasingly clear that mitochondria are critical regulators of how our bodies respond to disease.
Beyond their traditional job as “powerhouses of the cell,” mitochondria play key roles in the lives — and importantly, deaths — of cells to guide inflammation and antimicrobial defenses. This means mutations in mitochondrial-related genes could affect the immune system’s ability to fight off disease or even trigger an over-response, causing cancer or inflammatory disorders like Crohn’s disease.
Although there is a growing understanding of what mitochondria do to regulate the immune system, how they do it is still relatively unknown. Figuring out how mitochondrial mutations disturb immune response could be the key to understanding mechanisms for diseases such as tuberculosis, leprosy and Parkinson’s disease, and potentially open the door to new treatments.
A team of researchers recently unlocked part of that mystery in research published in the journal Cell. The researchers studied mutations in the protein LRRK2 in macrophages, or white blood cells, from animal models. When the mutated macrophages were exposed to the bacteria that causes tuberculosis, the mitochondria initiated a new type of cell death, switching from pyroptosis to necroptosis.
When cells die from necroptosis, they release chemical signals that cause an aggressive inflammatory immune response. For the animal models with LRRK2 mutations, the switch to necroptotic cell death made them more susceptible to tuberculosis infection and triggered excessive inflammation in the infected tissues, causing worse outcomes.
Although the study focused primarily on macrophages and tuberculosis infection, the newly discovered disease mechanism may have much wider implications.
“Mutations in the protein LRRK2 have been associated with multiple important human diseases that, at face value, have very little to do with each other — Parkinson’s disease, leprosy, inflammatory bowel and Crohn’s disease, and cancer,” the author said. “Our work demonstrates that a common mutation in LRRK2 triggers a new type of cell death that elicits hyperinflammation in response to infection. Cell death and inflammation could be the thing that connects LRRK2 to all these disparate human diseases.”
The team’s discovery has potential real-world applications that could provide much-needed relief for patients, and Patrick and Watson are ready to dive into the next phase of research by testing their theory using LRRK2 inhibitors already developed by pharmaceutical companies.
“Our research has positioned us to take these drugs and study them in the context of the immune response,” the author said. “We are about to embark on studies to see whether drugging LRRK2, as well as other proteins involved in this new cell death pathway, could improve tuberculosis infection outcomes.”
https://www.cell.com/cell/fulltext/S0092-8674(22)00790-5
Hidden connections between cell death and inflammation
- 1,087 views
- Added
Latest News
Abusive drugs hijack natura…
By newseditor
Posted 23 Apr
Mechanism of action of the…
By newseditor
Posted 23 Apr
Role of fat in rare neurolo…
By newseditor
Posted 23 Apr
How protein synthesis in de…
By newseditor
Posted 22 Apr
Atlas of mRNA variants in d…
By newseditor
Posted 22 Apr
Other Top Stories
New SARS-like virus can jump directly from bats to humans, no treat…
Read more
Developing universal antibody for alphaviruses
Read more
Mutation in coronavirus protein reduces its neurovirulence
Read more
Using copper to prevent the spread of respiratory viruses
Read more
How does human enterovirus D68 enters the cell?
Read more
Protocols
A programmable targeted pro…
By newseditor
Posted 23 Apr
MemPrep, a new technology f…
By newseditor
Posted 08 Apr
A tangible method to assess…
By newseditor
Posted 08 Apr
Stem cell-derived vessels-o…
By newseditor
Posted 06 Apr
Single-cell biclustering fo…
By newseditor
Posted 01 Apr
Publications
Exploiting pancreatic cance…
By newseditor
Posted 23 Apr
Structure of antiviral drug…
By newseditor
Posted 23 Apr
Type-I-interferon-responsiv…
By newseditor
Posted 23 Apr
Selenium, diabetes, and the…
By newseditor
Posted 23 Apr
Long-term neuropsychologica…
By newseditor
Posted 23 Apr
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar